Agios Pharmaceuticals Announces Initiation Of Four Expansion Cohorts In Phase 1 Study Of AG-221
October 15, 2014 at 07:32 AM EDT
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in the fields of cancer metabolism and rare genetic disorders of metabolism, today ...